[1]
B. O. Varynskyi and A. G. Kaplaushenko, “The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug”, Zaporozhye Medical Journal, no. 3, May 2017.